Estrogen replacement and exercise capacity in postmenopausal women: a randomized placebo-controlled study

Area of Science:

• Cardiovascular Physiology
• Exercise Science
• Endocrinology

Background:

• Menopause is associated with changes in body composition and cardiovascular risk.
• Hormone replacement therapy (HRT) has been investigated for its potential effects on cardiovascular health.

Purpose of the Study:

• To investigate the effects of oral estrogen replacement therapy on cardiopulmonary and functional capacities in postmenopausal women.
• To determine if estrogen therapy can enhance exercise performance and physiological responses during exertion.

Main Methods:

• A randomized controlled trial involving 23 postmenopausal women.
• Participants were assigned to receive either 2 mg of oral estradiol daily or a placebo for 90 days.
• Cardiopulmonary exercise testing was conducted before and after the intervention period.

Main Results:

• Estrogen replacement did not significantly alter resting or exercise blood pressure, heart rate, or pulmonary function.
• Oxygen consumption at the anaerobic threshold, respiratory compensation point, and peak exercise was reduced following estrogen treatment.
• No significant changes in workload or time to exhaustion were observed in the estrogen group, while the placebo group showed no changes.

Conclusions:

• Oral estrogen therapy does not enhance cardiopulmonary responses to submaximal and maximal exercise in postmenopausal women.
• Estrogen treatment failed to improve overall exercise capacity in this cohort.
• These findings suggest that estrogen replacement may not be beneficial for improving physical function in postmenopausal women.